Pafuramidine — CAS 58-38-0

Pafuramidine (DB289) is an orally bioavailable diamidine prodrug used in the treatment of African sleeping sickness (Trypanosoma brucei gambiense) and Pneumocystis pneumonia. Mediocon Inc manufactures this API at its GMP-certified facility in Aurangabad, Maharashtra, India, ensuring high purity and compliance with international pharmacopoeial standards.

• Treatment of African trypanosomiasis (sleeping sickness) — Stage 1
• Prophylaxis and treatment of Pneumocystis jirovecii pneumonia (PCP)
• Investigational use against Cryptosporidium infections
• Research tool in antiprotozoal drug studies

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support